RCM Technologies (RCMT)
Market Price (11/10/2026): $33.83 | Market Cap: $240.6 MilSector: Industrials | Industry: Industrial Conglomerates
RCM Technologies (RCMT)
Market Price (11/10/2026): $33.83Market Cap: $240.6 MilSector: IndustrialsIndustry: Industrial Conglomerates
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.1%, FCF Yield is 9.5% Megatrend and thematic driversMegatrends include Cloud Computing, Cybersecurity, and Artificial Intelligence. Themes include Hybrid Cloud Solutions, Show more. | Weak multi-year price returns3Y Excs Rtn is -2.9% | Valuation getting more expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 65% Key risksRCMT key risks include [1] its heavy concentration of revenue from a limited number of customers and specific business segments, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.1%, FCF Yield is 9.5% |
| Megatrend and thematic driversMegatrends include Cloud Computing, Cybersecurity, and Artificial Intelligence. Themes include Hybrid Cloud Solutions, Show more. |
| Weak multi-year price returns3Y Excs Rtn is -2.9% |
| Valuation getting more expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 65% |
| Key risksRCMT key risks include [1] its heavy concentration of revenue from a limited number of customers and specific business segments, Show more. |
Qualitative Assessment
AI Analysis | Feedback
RCM Technologies (RCMT) stock has gained about 20% since 7/31/2026 because of the following key factors:
1. Strong Fiscal Second Quarter 2026 Earnings Beat.
RCM Technologies (RCMT) announced robust financial results for its fiscal second quarter, which ended July 4, 2026, significantly exceeding analyst expectations. The company reported earnings per share (EPS) of $0.82, surpassing the consensus estimate of $0.62 by 32.26%. Additionally, revenue for the quarter reached $93.82 million, beating analyst estimates of $81.75 million by 14.76% and marking a 20.2% increase year-over-year. This strong performance also saw adjusted EBITDA increase by 49.0% compared to the prior quarter, and operating cash flow grow by over 54% in the first half of fiscal 2026.
2. Positive Analyst Sentiment and Increased Price Targets.
Following the strong fiscal Q2 2026 results, Wall Street analysts reacted positively by raising their price targets and maintaining "Buy" or "Strong Buy" ratings for RCMT. B. Riley increased its price target to $45 from $40, while Benchmark raised its target to $45 from $36, both reiterating Buy ratings on the shares. The average consensus price target among analysts is $45.00, suggesting a significant upside potential of approximately 25% to 39% from recent trading levels.
Show more
RCM Technologies (RCMT) stock has gained about 20% since 7/31/2026 because of the following key factors:
1. Strong Fiscal Second Quarter 2026 Earnings Beat.
RCM Technologies (RCMT) announced robust financial results for its fiscal second quarter, which ended July 4, 2026, significantly exceeding analyst expectations. The company reported earnings per share (EPS) of $0.82, surpassing the consensus estimate of $0.62 by 32.26%. Additionally, revenue for the quarter reached $93.82 million, beating analyst estimates of $81.75 million by 14.76% and marking a 20.2% increase year-over-year. This strong performance also saw adjusted EBITDA increase by 49.0% compared to the prior quarter, and operating cash flow grow by over 54% in the first half of fiscal 2026.
2. Positive Analyst Sentiment and Increased Price Targets.
Following the strong fiscal Q2 2026 results, Wall Street analysts reacted positively by raising their price targets and maintaining "Buy" or "Strong Buy" ratings for RCMT. B. Riley increased its price target to $45 from $40, while Benchmark raised its target to $45 from $36, both reiterating Buy ratings on the shares. The average consensus price target among analysts is $45.00, suggesting a significant upside potential of approximately 25% to 39% from recent trading levels.
3. Sustained Growth Across Key Business Segments.
The company's impressive financial performance was underpinned by continued strength and growth across its core business segments. The Specialty Health Care segment remained a consistent and significant earnings contributor, while the Engineering and Life Sciences, Data and Solutions segments experienced substantial revenue gains of 49.0% and 8.4% respectively, during fiscal Q2 2026. This growth was attributed to a strong project backlog, a robust pipeline, and improving demand within critical sectors such as energy utilities and data center development.
Show less
Stock Movement Drivers
Fundamental Drivers
The 19.5% change in RCMT stock from 7/31/2026 to 11/9/2026 was primarily driven by a 9.2% change in the company's P/E Multiple.| (LTM values as of) | 7312026 | 11092026 | Change |
|---|---|---|---|
| Stock Price ($) | 28.29 | 33.82 | 19.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 318 | 334 | 4.9% |
| Net Income Margin (%) | 5.0% | 5.1% | 2.0% |
| P/E Multiple | 12.8 | 14.0 | 9.2% |
| Shares Outstanding (Mil) | 7 | 7 | 2.4% |
| Cumulative Contribution | 19.5% |
Market Drivers
7/31/2026 to 11/9/2026| Return | Correlation | |
|---|---|---|
| RCMT | 19.5% | |
| Market (SPY) | 0.8% | 25.4% |
| Sector (XLI) | -6.1% | 24.0% |
Fundamental Drivers
The 8.1% change in RCMT stock from 4/30/2026 to 11/9/2026 was primarily driven by a 4.5% change in the company's Total Revenues ($ Mil).| (LTM values as of) | 4302026 | 11092026 | Change |
|---|---|---|---|
| Stock Price ($) | 31.29 | 33.82 | 8.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 319 | 334 | 4.5% |
| Net Income Margin (%) | 5.1% | 5.1% | 0.3% |
| P/E Multiple | 14.1 | 14.0 | -0.7% |
| Shares Outstanding (Mil) | 7 | 7 | 3.9% |
| Cumulative Contribution | 8.1% |
Market Drivers
4/30/2026 to 11/9/2026| Return | Correlation | |
|---|---|---|
| RCMT | 8.1% | |
| Market (SPY) | 5.0% | 21.0% |
| Sector (XLI) | -3.0% | 21.3% |
Fundamental Drivers
The 46.4% change in RCMT stock from 10/31/2025 to 11/9/2026 was primarily driven by a 13.2% change in the company's Net Income Margin (%).| (LTM values as of) | 10312025 | 11092026 | Change |
|---|---|---|---|
| Stock Price ($) | 23.10 | 33.82 | 46.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 300 | 334 | 11.2% |
| Net Income Margin (%) | 4.5% | 5.1% | 13.2% |
| P/E Multiple | 12.6 | 14.0 | 11.2% |
| Shares Outstanding (Mil) | 7 | 7 | 4.5% |
| Cumulative Contribution | 46.4% |
Market Drivers
10/31/2025 to 11/9/2026| Return | Correlation | |
|---|---|---|
| RCMT | 46.4% | |
| Market (SPY) | 11.3% | 24.2% |
| Sector (XLI) | 9.9% | 18.5% |
Fundamental Drivers
The 70.6% change in RCMT stock from 10/31/2023 to 11/9/2026 was primarily driven by a 37.8% change in the company's P/E Multiple.| (LTM values as of) | 10312023 | 11092026 | Change |
|---|---|---|---|
| Stock Price ($) | 19.82 | 33.82 | 70.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 263 | 334 | 27.1% |
| Net Income Margin (%) | 6.2% | 5.1% | -16.8% |
| P/E Multiple | 10.2 | 14.0 | 37.8% |
| Shares Outstanding (Mil) | 8 | 7 | 17.1% |
| Cumulative Contribution | 70.6% |
Market Drivers
10/31/2023 to 11/9/2026| Return | Correlation | |
|---|---|---|
| RCMT | 70.6% | |
| Market (SPY) | 86.2% | 25.0% |
| Sector (XLI) | 78.6% | 25.0% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| RCMT Return | 244% | 73% | 135% | -24% | -8% | 65% | 1534% |
| Peers Return | 31% | -10% | 10% | -14% | -18% | 38% | 28% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 8% | 96% |
Monthly Win Rates [3] | |||||||
| RCMT Win Rate | 75% | 42% | 75% | 50% | 50% | 55% | |
| Peers Win Rate | 65% | 50% | 52% | 48% | 45% | 58% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 36% | |
Max Drawdowns [4] | |||||||
| RCMT Max Drawdown | -47% | -58% | -32% | -43% | -33% | -33% | |
| Peers Max Drawdown | -21% | -33% | -25% | -35% | -34% | -33% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: AMN, CTSH, KBR, J, KELYA.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 11/9/2026 (YTD)
How Low Can It Go
| Event | RCMT | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -24.6% | -18.8% |
| % Gain to Breakeven | 32.6% | 23.1% |
| Time to Breakeven | 50 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -11.4% | -9.5% |
| % Gain to Breakeven | 12.8% | 10.5% |
| Time to Breakeven | 4 days | 24 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -24.6% | -6.7% |
| % Gain to Breakeven | 32.7% | 7.1% |
| Time to Breakeven | 49 days | 31 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -17.1% | -24.5% |
| % Gain to Breakeven | 20.6% | 32.4% |
| Time to Breakeven | 15 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -58.2% | -33.7% |
| % Gain to Breakeven | 139.3% | 50.9% |
| Time to Breakeven | 315 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -35.6% | -19.2% |
| % Gain to Breakeven | 55.3% | 23.8% |
| Time to Breakeven | 49 days | 105 days |
In The Past
RCM Technologies's stock fell -24.6% during the 2025 US Tariff Shock. Such a loss loss requires a 32.6% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | RCMT | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -24.6% | -18.8% |
| % Gain to Breakeven | 32.6% | 23.1% |
| Time to Breakeven | 50 days | 79 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -24.6% | -6.7% |
| % Gain to Breakeven | 32.7% | 7.1% |
| Time to Breakeven | 49 days | 31 days |
| 2020 COVID-19 Crash | ||
| % Loss | -58.2% | -33.7% |
| % Gain to Breakeven | 139.3% | 50.9% |
| Time to Breakeven | 315 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -35.6% | -19.2% |
| % Gain to Breakeven | 55.3% | 23.8% |
| Time to Breakeven | 49 days | 105 days |
| 2016-2017 Trump Reflation Bond Selloff | ||
| % Loss | -28.2% | -3.7% |
| % Gain to Breakeven | 39.4% | 3.9% |
| Time to Breakeven | 216 days | 6 days |
| 2014-2016 Oil Price Collapse | ||
| % Loss | -22.1% | -6.8% |
| % Gain to Breakeven | 28.4% | 7.3% |
| Time to Breakeven | 123 days | 15 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -28.6% | -17.9% |
| % Gain to Breakeven | 40.0% | 21.8% |
| Time to Breakeven | 138 days | 123 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -85.6% | -53.4% |
| % Gain to Breakeven | 594.3% | 114.4% |
| Time to Breakeven | 1463 days | 1085 days |
| Summer 2007 Credit Crunch | ||
| % Loss | -27.2% | -8.6% |
| % Gain to Breakeven | 37.4% | 9.5% |
| Time to Breakeven | 2559 days | 47 days |
In The Past
RCM Technologies's stock fell -24.6% during the 2025 US Tariff Shock. Such a loss loss requires a 32.6% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About RCM Technologies (RCMT)
RCM Technologies, Inc. (RCMT) is a diversified professional services company that delivers business and technology solutions across the United States, Canada, Puerto Rico, and Serbia. The company operates through three distinct segments: Engineering, Specialty Health Care, and Life Sciences and Information Technology, catering to a broad spectrum of industries and client needs.
In its Engineering segment, RCMT offers comprehensive services such as project management, design, engineering analysis, and technical documentation, primarily serving the aerospace and defense, energy, and manufacturing sectors. The Specialty Health Care segment focuses on providing critical staffing and executive search services, encompassing allied health, nursing, physician, and correctional healthcare roles, for various healthcare providers and educational institutions.
Complementing these, the Life Sciences and Information Technology segment delivers enterprise business solutions, application and infrastructure services, and specialized offerings for the life sciences industry. This segment broadly serves financial services, healthcare, technology, manufacturing, education, and public sector clients, providing a wide array of IT and strategic consulting services.
AI Analysis | Feedback
Here are 1-3 brief analogies for RCM Technologies (RCMT):
Imagine a smaller, specialized version of Accenture, providing a mix of technology, engineering, and business solutions, alongside extensive healthcare staffing services.
Think of a blend between AMN Healthcare (for its specialized medical staffing) and an engineering and IT consulting firm like Capgemini.
AI Analysis | Feedback
- Engineering Services: Provides a full spectrum of engineering support, including design, analysis, project management, and technical documentation for various industries.
- Healthcare Staffing and Recruitment: Offers temporary and permanent placement of healthcare professionals, therapists, nurses, and physicians across diverse healthcare settings.
- IT and Life Sciences Solutions: Delivers comprehensive information technology services, such as enterprise business solutions, application development, infrastructure management, and specialized life sciences technology support.
AI Analysis | Feedback
RCM Technologies (RCMT) primarily sells its business and technology solutions, as well as staffing services, to other companies and organizations.
Based on the provided company description, specific major customer company names are not disclosed. However, RCM Technologies serves a diverse client base across numerous industries and sectors. Its major customers can be categorized by the industries and types of organizations it serves, which include:
- Aerospace and Defense industry
- Energy industry
- Financial Services industry
- Health Care industry
- Life Sciences industry
- Manufacturing and Distribution industry
- Technology industry
- Educational Institutions
- The Public Sector
AI Analysis | Feedback
AI Analysis | Feedback
Bradley S. Vizi, Executive Chairman & President
Bradley S. Vizi is a primary force in the governance and strategy of RCM Technologies, Inc., holding a substantial individual ownership stake in the company. He is the largest individual shareholder, owning 19% of the outstanding shares as of July 3, 2025. Mr. Vizi has emphasized the importance of share count reductions to improve shareholder returns and has overseen significant share buybacks. He has been actively involved in the company's leadership for an extended period.
Kevin D. Miller, Chief Financial Officer, Treasurer, Principal Accounting Officer and Secretary
Kevin D. Miller has served as the Chief Financial Officer, Secretary, and Treasurer at RCM Technologies Inc. since October 2008. Prior to this role, he was the Senior Vice President of RCM from July 1997 to September 2008. Mr. Miller also worked as an Associate in the Corporate Finance Department of Legg Mason Wood Walker, Incorporated from 1996 to 1997, and as a Business Consultant for the Wharton Small Business Development Center from 1995 to 1996. His earlier experience includes serving as an Associate in both the audit and corporate finance groups at Ernst & Young LLP.
Michael Saks, Division President, Health Care Services
Michael Saks oversees the Health Care Services segment, which generates the majority of RCM Technologies' revenue.
Tina Ciocca, Executive Vice President, Aerospace & Defense
Tina Ciocca holds the position of Executive Vice President, Aerospace & Defense at RCM Technologies.
William Gargano, Group Senior Vice President, Life Sciences & IT Services
William Gargano serves as the Group Senior Vice President for the Life Sciences & IT Services segment of RCM Technologies.
```AI Analysis | Feedback
Here are the key risks to the business of RCM Technologies (RCMT):
-
Economic Factors, Market Demand Fluctuations, and Wage Inflation: RCM Technologies is significantly exposed to the broader economic environment, which can impact client capital expenditure budgets and demand for its services. Persistent inflation and high interest rates have been noted to pressure capital expenditure for IT and Engineering clients, leading to a slowdown in discretionary IT/Consulting and Life Sciences & Data Solutions. The company's gross profit in the Life Sciences & Data Solutions segment declined by 4.2% year-over-year in Q3 2025. Furthermore, the Specialty Health Care segment experienced an 11% decline in revenue due to reduced demand for travel nurse services and challenging comparisons to prior COVID-related revenues. Wage inflation, particularly in the nursing sector, also squeezes profit margins. Operational inefficiencies, reflected in lower utilization rates, have also contributed to a decrease in gross margin.
-
Cybersecurity Threats and Data Privacy: As a provider of technology solutions, RCM Technologies faces ongoing risks from cybersecurity threats. If realized, these threats could materially affect the company's operations, business strategy, results of operations, or financial condition. The company's 10-K filings explicitly mention risks related to cybersecurity, data privacy, data center capacity, and telecommunication links.
-
Dependence on a Concentrated Group of Customers: A significant portion of RCM Technologies' condensed consolidated revenues is contributed by a concentrated group of customers. This customer concentration poses a risk, as the loss of one or more major clients or a significant reduction in business from them could materially and adversely affect the company's financial performance and results of operations.
AI Analysis | Feedback
The emergence of advanced AI and machine learning-driven staffing platforms and recruitment technologies poses a clear threat to RCM Technologies' Specialty Health Care segment. These platforms automate candidate sourcing, matching, and screening, potentially offering faster, more cost-effective, and efficient recruitment solutions that could disintermediate traditional human-centric staffing agencies.
Additionally, the rapid advancements in hyper-automation, AI-powered development tools (e.g., low-code/no-code platforms, generative AI for code), and increasingly integrated cloud-native services from major providers threaten to commoditize or significantly alter the demand for traditional enterprise business solutions, application services, and infrastructure solutions within RCM Technologies' Life Sciences and Information Technology segment. This could reduce the need for human-intensive IT services that RCMT currently provides, shifting value towards highly specialized consulting or platform-specific integration.
AI Analysis | Feedback
RCM Technologies operates within three main segments, each addressing significant market opportunities:
- Engineering: The global engineering services market was valued at approximately USD 2.34 trillion in 2025 and is projected to grow to USD 5.37 trillion by 2034, exhibiting a compound annual growth rate (CAGR) of 10.60% from 2026 to 2034. For the U.S. specifically, the market size was estimated at USD 0.45 trillion in 2026.
- Specialty Health Care: The U.S. healthcare staffing market, which includes long-term and short-term staffing, executive search, and placement services, was estimated at USD 45.48 billion in 2025. It is projected to reach USD 89.71 billion by 2033, growing at a CAGR of 6.98% from 2026 to 2033.
-
Life Sciences and Information Technology: This segment encompasses two primary areas:
- Life Sciences IT/Software: The global life sciences IT market was estimated at USD 25.45 billion in 2024 and is expected to reach USD 69.01 billion in 2034, expanding at a CAGR of 10.49% over the forecast period of 2025-2034. In North America, the market was valued at US$ 35.42 billion in 2024 and is anticipated to reach approximately US$ 110.75 billion by 2034, expanding at a CAGR of 12.08% from 2025 to 2034.
- IT Consulting Services: The global IT consulting services market was valued at approximately USD 78.03 billion in 2024 and is projected to reach USD 129.15 billion by 2034, growing at a CAGR of roughly 6.50% between 2025 and 2034.
AI Analysis | Feedback
RCM Technologies (RCMT) is expected to drive future revenue growth over the next 2-3 years through several key initiatives across its segments:
- Expansion of Specialty Health Care Services: The company anticipates continued growth in its Specialty Health Care segment, particularly in school-related services. This growth is projected to be around 20% for the school year spanning July 2024 to June 2025, supported by the acquisition of over 20 new school contracts. Additionally, RCM Technologies is broadening its K-12 behavioral health services and Health Information Management (HIM) offerings, and it possesses a robust pipeline of international nurses expected to accelerate growth in both healthcare and education sectors.
- Growth in Engineering Services from Infrastructure and Aerospace: RCM Technologies is well-positioned for growth in its Engineering segment, leveraging significant trends such as grid modernization and data center expansion. The company has secured multi-year preferred partner agreements for comprehensive engineering services and has a record engineering backlog of over $70 million for 2026, a substantial increase from the prior year. Its Aerospace Group also demonstrated strong performance, exceeding its Q1 2025 business plan objectives by over 20% in revenue.
- Advancements and New Client Acquisition in Life Sciences and Information Technology: The Life Sciences and Information Technology segment is expected to grow through high-value managed service offerings, particularly in commercialization, data integrity, and quality improvement programs. RCM Technologies is actively securing new clients in the pharmaceutical and biotech sectors and is investing in AI-driven equipment qualification and data integrity solutions to streamline compliance and enhance audit readiness. The broader Revenue Cycle Management (RCM) market, relevant to their IT services, is also projected to grow significantly, driven by AI adoption.
AI Analysis | Feedback
Share Repurchases
- RCM Technologies has consistently repurchased shares over the last 3-5 years, leading to a significant reduction in common shares outstanding. The number of shares outstanding decreased from 10.29 million at the end of 2021 to 7.41 million at the end of 2025.
- In the last year, the number of shares outstanding decreased by 4.33%.
Share Issuance
- There have been no significant share issuances over the last 3-5 years, with the overall trend showing a decrease in outstanding shares.
Capital Expenditures
- Capital expenditures were $3 million in 2023 and $3 million in 2024.
- In the last 12 months, capital expenditures totaled -$2.38 million.
- Capital expenditures are projected to be $2 million annually from 2025 to 2029, representing approximately 1% of revenue.
Peer Outperformance in Industrial Conglomerates
| Industry | Names | 1Y med | 3Y med | 5Y med | Top 3 by 5Y |
|---|---|---|---|---|---|
| Construction & Engineering | 28 | -13.7% | 106.4% | 114.2% | FIX 1047% · STRL 907% · AGX 633% |
| Marine Transportation | 5 | 34.7% | 32.6% | 113.6% | MATX 140% · KEX 117% |
| Construction Machinery & Heavy Transportation Equipment | 14 | 13.2% | 69.5% | 98.2% | ALSN 278% · WAB 218% · CAT 210% |
| Aerospace & Defense | 54 | 3.9% | 57.7% | 65.2% | FTAI 963% · ATI 954% · HWM 563% |
| Industrial Machinery & Supplies & Components | 71 | 4.3% | 53.9% | 33.5% | CRS 853% · MLI 306% · SYM 276% |
| Trading Companies & Distributors | 19 | 15.2% | 35.5% | 28.4% | DXPE 338% · AIT 199% · URI 199% |
| Rail Transportation | 7 | 36.9% | 71.5% | 27.2% | CSX 52% · UNP 38% · NSC 27% |
| Diversified Support Services | 34 | 19.2% | 46.7% | 18.5% | CXW 205% · OPLN 140% · CACI 124% |
| Building Products | 34 | -3.3% | 8.5% | 16.5% | MOD 813% · GFF 365% · TT 136% |
| Cargo Ground Transportation | 16 | 33.6% | 16.2% | 5.2% | XPO 299% · R 262% · ARCB 22% |
| Electrical Components & Equipment | 39 | 0.2% | 61.0% | 0.6% | POWL 1531% · VRT 647% · BE 465% |
| Office Services & Supplies | 10 | 22.4% | 27.1% | -1.2% | PBI 146% · HNI 45% · MSA 19% |
| Industrial Conglomerates ← | 17 | 19.2% | 12.4% | -3.3% | CSW 109% · CSL 78% · DD 76% |
| Data Processing & Outsourced Services | 6 | -8.1% | 2.7% | -13.8% | EXLS 60% · BR 18% · G -10% |
| Agricultural & Farm Machinery | 16 | 23.0% | -0.4% | -22.9% | BLBD 147% · DE 107% · TTC 16% |
| Research & Consulting Services | 13 | 1.9% | -15.6% | -23.5% | HURN 209% · FCN 36% · BAH 9% |
| Security & Alarm Services | 9 | -39.6% | 45.7% | -24.9% | BCO 83% |
| Environmental & Facilities Services | 29 | -20.7% | 33.3% | -26.4% | GEO 222% · CLH 168% · RSG 97% |
| Passenger Airlines | 11 | 11.0% | 85.0% | -29.1% | LTM 3253% · UAL 128% · DAL 114% |
| Human Resource & Employment Services | 22 | 23.8% | -5.4% | -36.3% | ADP 47% · FA 20% · PAYX 10% |
| Air Freight & Logistics | 12 | -29.9% | -5.7% | -39.9% | FDX 76% · EXPD 60% · CHRW 54% |
| Passenger Ground Transportation | 3 | -22.6% | 38.0% | -46.2% | UBER 56% · CAR -46% · LYFT -70% |
| Airport Services | 4 | -38.1% | -57.1% | -85.7% | JOBY -35% |
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| RCM Technologies Earnings Notes | 12/16/2025 | |
| Would You Still Hold RCM Technologies Stock If It Fell 30%? | 10/17/2025 |
| Title | |
|---|---|
| ARTICLES |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 38.17 |
| Mkt Cap | 3.2 |
| Rev LTM | 5,938 |
| Op Inc LTM | 384 |
| FCF LTM | 327 |
| FCF 3Y Avg | 318 |
| CFO LTM | 371 |
| CFO 3Y Avg | 371 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 8.1% |
| Rev Chg 3Y Avg | 4.4% |
| Rev Chg Q | 9.0% |
| QoQ Delta Rev Chg LTM | 1.8% |
| Op Inc Chg LTM | 5.3% |
| Op Inc Chg 3Y Avg | 7.3% |
| Op Mgn LTM | 6.5% |
| Op Mgn 3Y Avg | 6.4% |
| QoQ Delta Op Mgn LTM | 0.1% |
| CFO/Rev LTM | 6.1% |
| CFO/Rev 3Y Avg | 7.0% |
| FCF/Rev LTM | 5.7% |
| FCF/Rev 3Y Avg | 6.2% |
Segment Financials
Revenue by Segment| $ Mil | 2026 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Specialty Health Care | 164 | 143 | 136 | 159 |
| Engineering | 120 | 96 | 85 | 86 |
| Life Sciences, Data & Solutions | 35 | 39 | 42 | 39 |
| Corporate | 0 | 0 | 0 | 0 |
| Total | 319 | 278 | 263 | 285 |
| $ Mil | 2026 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Specialty Health Care | 23 | 12 | 14 | 20 |
| Engineering | 15 | 4 | 4 | 4 |
| Life Sciences, Data & Solutions | 6 | 6 | 7 | 5 |
| Corporate | -19 | -0 | 0 | 0 |
| Total | 25 | 22 | 24 | 29 |
| $ Mil | 2026 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Engineering | 61 | 52 | 46 | 33 |
| Specialty Health Care | 47 | 43 | 44 | 34 |
| Life Sciences, Data & Solutions | 14 | 22 | 19 | 16 |
| Corporate | 13 | 15 | 12 | 5 |
| Total | 134 | 132 | 120 | 88 |
Price Behavior
| Market Price | $33.82 | |
| Market Cap ($ Bil) | 0.2 | |
| First Trading Date | 08/18/1995 | |
| Distance from 52W High | -19.5% | |
| 50 Days | 200 Days | |
| DMA Price | $38.96 | $29.07 |
| DMA Trend | up | up |
| Distance from DMA | -13.2% | 16.4% |
| 3M | 1YR | |
| Volatility | 62.5% | 58.4% |
| Downside Capture | -50.95 | 72.97 |
| Upside Capture | 2.38 | 108.37 |
| Correlation (S&P 500) | 20.2% | 22.6% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 0.64 | 0.80 | 0.25 | 0.44 | 0.88 | 0.76 |
| Up Beta | -7.24 | 0.40 | 1.04 | 0.20 | 0.35 | 0.64 |
| Down Beta | 0.93 | 1.19 | 1.93 | 1.45 | 1.31 | 0.55 |
| Up Capture | -35% | 15% | 21% | 32% | 116% | 90% |
| Bmk +ve Days | 12 | 18 | 28 | 62 | 130 | 427 |
| Stock +ve Days | 6 | 16 | 29 | 65 | 122 | 354 |
| Down Capture | 175% | 139% | -127% | 9% | 78% | 99% |
| Bmk -ve Days | 10 | 25 | 36 | 64 | 121 | 325 |
| Stock -ve Days | 16 | 27 | 35 | 60 | 128 | 391 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with RCMT | |
|---|---|---|---|---|
| RCMT | 52.7% | 58.4% | 0.92 | - |
| Sector ETF (XLI) | 11.7% | 18.2% | 0.45 | 18.3% |
| Equity (SPY) | 13.3% | 13.7% | 0.65 | 23.7% |
| Gold (GLD) | 3.7% | 28.8% | 0.12 | 0.9% |
| Commodities (DBC) | 38.2% | 21.3% | 1.42 | -5.1% |
| Real Estate (VNQ) | 13.7% | 14.3% | 0.65 | 12.4% |
| Bitcoin (BTCUSD) | -25.3% | 43.6% | -0.55 | 16.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with RCMT | |
|---|---|---|---|---|
| RCMT | 38.8% | 62.0% | 0.77 | - |
| Sector ETF (XLI) | 11.6% | 17.8% | 0.49 | 22.8% |
| Equity (SPY) | 11.8% | 17.3% | 0.51 | 24.7% |
| Gold (GLD) | 17.8% | 19.1% | 0.75 | -0.6% |
| Commodities (DBC) | 8.0% | 19.6% | 0.29 | 3.9% |
| Real Estate (VNQ) | 1.5% | 18.9% | -0.03 | 17.5% |
| Bitcoin (BTCUSD) | 4.4% | 51.6% | 0.27 | 13.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with RCMT | |
|---|---|---|---|---|
| RCMT | 18.1% | 66.8% | 0.52 | - |
| Sector ETF (XLI) | 13.3% | 20.1% | 0.58 | 20.5% |
| Equity (SPY) | 15.3% | 18.0% | 0.72 | 20.9% |
| Gold (GLD) | 12.1% | 16.5% | 0.60 | 0.1% |
| Commodities (DBC) | 7.6% | 18.1% | 0.33 | 5.6% |
| Real Estate (VNQ) | 6.1% | 20.7% | 0.25 | 17.9% |
| Bitcoin (BTCUSD) | 60.0% | 66.3% | 1.00 | 11.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Updated 8/31/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 4/3/2026 | 32.0% | 39.5% | 61.5% |
| 11/5/2025 | -5.0% | -17.3% | -14.2% |
| 8/7/2025 | 0.0% | 8.7% | 20.8% |
| 5/7/2025 | 15.9% | 28.8% | 30.2% |
| 3/12/2025 | -13.5% | -16.2% | -8.9% |
| 11/7/2024 | 4.2% | -1.8% | 5.7% |
| 8/7/2024 | 6.1% | 2.9% | 4.6% |
| 5/8/2024 | 8.0% | 16.3% | 1.9% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 10 | 11 | 14 |
| # Negative | 9 | 8 | 5 |
| Median Positive | 10.8% | 8.7% | 20.4% |
| Median Negative | -6.6% | -10.4% | -14.2% |
| Max Positive | 44.6% | 69.1% | 88.1% |
| Max Negative | -24.9% | -19.0% | -32.3% |
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 4/3/2026 | 32.0% | 39.5% | 61.5% |
| 11/5/2025 | -5.0% | -17.3% | -14.2% |
| 8/7/2025 | 0.0% | 8.7% | 20.8% |
| 5/7/2025 | 15.9% | 28.8% | 30.2% |
| 3/12/2025 | -13.5% | -16.2% | -8.9% |
| 11/7/2024 | 4.2% | -1.8% | 5.7% |
| 8/7/2024 | 6.1% | 2.9% | 4.6% |
| 5/8/2024 | 8.0% | 16.3% | 1.9% |
| 3/13/2024 | -24.9% | -19.0% | -32.3% |
| 11/8/2023 | 14.1% | 26.4% | 41.0% |
| 8/9/2023 | -10.1% | 1.7% | 0.9% |
| 4/28/2023 | 13.5% | 8.5% | 41.9% |
| 11/9/2022 | -4.6% | -9.6% | -21.8% |
| 8/10/2022 | -21.3% | -11.1% | -11.6% |
| 4/27/2022 | 44.6% | 69.1% | 88.1% |
| 11/12/2021 | 0.2% | 8.4% | 4.8% |
| 8/12/2021 | -6.6% | -1.7% | 54.8% |
| 5/13/2021 | -0.6% | 8.3% | 6.8% |
| 11/10/2020 | -0.7% | -1.4% | 20.0% |
| SUMMARY STATS | |||
| # Positive | 10 | 11 | 14 |
| # Negative | 9 | 8 | 5 |
| Median Positive | 10.8% | 8.7% | 20.4% |
| Median Negative | -6.6% | -10.4% | -14.2% |
| Max Positive | 44.6% | 69.1% | 88.1% |
| Max Negative | -24.9% | -19.0% | -32.3% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2026 | 08/13/2026 | 10-Q |
| 03/31/2026 | 05/14/2026 | 10-Q |
| 12/31/2025 | 04/03/2026 | 10-K |
| 09/30/2025 | 11/06/2025 | 10-Q |
| 06/30/2025 | 08/07/2025 | 10-Q |
| 03/31/2025 | 05/08/2025 | 10-Q |
| 12/31/2024 | 03/13/2025 | 10-K |
| 09/30/2024 | 11/07/2024 | 10-Q |
| 06/30/2024 | 08/08/2024 | 10-Q |
| 03/31/2024 | 05/09/2024 | 10-Q |
| 12/31/2023 | 03/14/2024 | 10-K |
| 09/30/2023 | 11/09/2023 | 10-Q |
| 06/30/2023 | 08/10/2023 | 10-Q |
| 03/31/2023 | 05/10/2023 | 10-Q |
| 12/31/2022 | 03/16/2023 | 10-K |
| 09/30/2022 | 11/10/2022 | 10-Q |
| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2026 | 08/13/2026 | 10-Q |
| 03/31/2026 | 05/14/2026 | 10-Q |
| 12/31/2025 | 04/03/2026 | 10-K |
| 09/30/2025 | 11/06/2025 | 10-Q |
| 06/30/2025 | 08/07/2025 | 10-Q |
| 03/31/2025 | 05/08/2025 | 10-Q |
| 12/31/2024 | 03/13/2025 | 10-K |
| 09/30/2024 | 11/07/2024 | 10-Q |
| 06/30/2024 | 08/08/2024 | 10-Q |
| 03/31/2024 | 05/09/2024 | 10-Q |
| 12/31/2023 | 03/14/2024 | 10-K |
| 09/30/2023 | 11/09/2023 | 10-Q |
| 06/30/2023 | 08/10/2023 | 10-Q |
| 03/31/2023 | 05/10/2023 | 10-Q |
| 12/31/2022 | 03/16/2023 | 10-K |
| 09/30/2022 | 11/10/2022 | 10-Q |
| 06/30/2022 | 08/11/2022 | 10-Q |
| 03/31/2022 | 04/28/2022 | 10-Q |
| 12/31/2021 | 04/04/2022 | 10-K |
| 09/30/2021 | 11/12/2021 | 10-Q |
| 06/30/2021 | 08/13/2021 | 10-Q |
| 03/31/2021 | 05/14/2021 | 10-Q |
| 12/31/2020 | 04/02/2021 | 10-K |
| 09/30/2020 | 11/10/2020 | 10-Q |
| 06/30/2020 | 08/11/2020 | 10-Q |
| 03/31/2020 | 05/12/2020 | 10-Q |
| 12/31/2019 | 03/05/2020 | 10-K |
| 09/30/2019 | 11/07/2019 | 10-Q |
Insider Activity
Updated 8/27/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Miller, Kevin D | CFO | Direct | Sell | 8272026 | 42.05 | 1,753 | 73,714 | 13,912,789 | Form |
| 2 | Miller, Kevin D | CFO | Direct | Sell | 8272026 | 42.00 | 1,333 | 55,986 | 13,969,872 | Form |
| 3 | Saks, Michael | Division President, HC Srvs. | Direct | Sell | 8252026 | 41.12 | 706 | 29,031 | 3,643,273 | Form |
| 4 | Saks, Michael | Division President, HC Srvs. | Direct | Sell | 8202026 | 41.07 | 10,000 | 410,682 | 3,667,677 | Form |
| 5 | Miller, Kevin D | CFO | Direct | Sell | 8182026 | 42.00 | 4,413 | 185,346 | 14,025,858 | Form |
| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Miller, Kevin D | CFO | Direct | Sell | 8272026 | 42.05 | 1,753 | 73,714 | 13,912,789 | Form |
| 2 | Miller, Kevin D | CFO | Direct | Sell | 8272026 | 42.00 | 1,333 | 55,986 | 13,969,872 | Form |
| 3 | Saks, Michael | Division President, HC Srvs. | Direct | Sell | 8252026 | 41.12 | 706 | 29,031 | 3,643,273 | Form |
| 4 | Saks, Michael | Division President, HC Srvs. | Direct | Sell | 8202026 | 41.07 | 10,000 | 410,682 | 3,667,677 | Form |
| 5 | Miller, Kevin D | CFO | Direct | Sell | 8182026 | 42.00 | 4,413 | 185,346 | 14,025,858 | Form |
| 6 | Miller, Kevin D | CFO | Direct | Sell | 8182026 | 37.98 | 60,000 | 2,279,018 | 12,852,218 | Form |
| 7 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 8182026 | 38.86 | 74,719 | 2,903,266 | 54,494,356 | Form |
| 8 | Miller, Kevin D | CFO | Direct | Sell | 8182026 | 34.02 | 30,000 | 1,020,600 | 13,552,275 | Form |
| 9 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 8182026 | 35.02 | 25,281 | 885,341 | 51,731,404 | Form |
| 10 | Saks, Michael | Division President, HC Srvs. | Direct | Sell | 8172026 | 33.56 | 11,792 | 395,740 | 3,332,747 | Form |
| 11 | Saks, Michael | Division President, HC Srvs. | Direct | Sell | 5062026 | 32.50 | 1,208 | 39,260 | 2,901,178 | Form |
| 12 | Miller, Kevin D | CFO | Direct | Sell | 5062026 | 32.03 | 19,066 | 610,684 | 13,452,600 | Form |
| 13 | Miller, Kevin D | CFO | Direct | Sell | 4292026 | 32.00 | 4,734 | 151,488 | 14,050,112 | Form |
| 14 | Miller, Kevin D | CFO | Direct | Sell | 4242026 | 32.04 | 2,932 | 93,941 | 14,219,352 | Form |
| 15 | Miller, Kevin D | CFO | Direct | Sell | 4242026 | 32.00 | 1,483 | 47,456 | 14,295,424 | Form |
| 16 | Miller, Kevin D | CFO | Direct | Sell | 4212026 | 32.02 | 2,385 | 76,368 | 14,351,844 | Form |
| 17 | Miller, Kevin D | CFO | Direct | Sell | 4212026 | 32.00 | 3,000 | 96,000 | 14,419,200 | Form |
| 18 | Saks, Michael | Division President, HC Srvs. | Direct | Sell | 4172026 | 30.00 | 4,864 | 145,920 | 3,144,420 | Form |
| 19 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 4172026 | 30.00 | 49,860 | 1,495,800 | 45,074,310 | Form |
| 20 | Saks, Michael | Division President, HC Srvs. | Direct | Sell | 4172026 | 30.00 | 136 | 4,080 | 3,290,340 | Form |
| 21 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 4172026 | 30.00 | 140 | 4,200 | 46,570,110 | Form |
| 22 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 4092026 | 27.52 | 8,237 | 226,682 | 40,983,885 | Form |
| 23 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 4092026 | 27.55 | 13,666 | 376,498 | 41,255,491 | Form |
| 24 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 10012025 | 27.50 | 160 | 4,400 | 41,557,258 | Form |
| 25 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 9242025 | 27.55 | 8 | 220 | 41,637,224 | Form |
| 26 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 9242025 | 27.50 | 85 | 2,338 | 41,561,878 | Form |
| 27 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 9242025 | 27.50 | 1,165 | 32,038 | 41,564,215 | Form |
| 28 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 9192025 | 27.50 | 3,825 | 105,188 | 41,596,252 | Form |
| 29 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 9192025 | 27.50 | 2,620 | 72,050 | 41,701,440 | Form |
| 30 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 9192025 | 27.51 | 2,811 | 77,331 | 41,788,680 | Form |
| 31 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 9122025 | 27.53 | 658 | 18,115 | 41,896,448 | Form |
| 32 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 9122025 | 27.50 | 300 | 8,250 | 41,868,888 | Form |
| 33 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 9092025 | 27.50 | 4 | 110 | 41,877,138 | Form |
| 34 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 9092025 | 27.51 | 3,961 | 108,967 | 41,892,476 | Form |
| 35 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 9092025 | 27.50 | 4,508 | 123,970 | 41,986,175 | Form |
| 36 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 9032025 | 27.50 | 673 | 18,508 | 42,110,145 | Form |
| 37 | Vizi, Bradley | Executive Chairman & President | Direct | Sell | 8282025 | 27.51 | 7,289 | 200,520 | 42,143,972 | Form |
| 38 | Saks, Michael | Division President, HC Srvs. | Direct | Sell | 8282025 | 27.50 | 5,000 | 137,500 | 3,012,542 | Form |
Industry Resources
| Industrials Resources |
| IndustryWeek |
| Manufacturing.net |
| Aviation Week |
| Industrial Conglomerates Resources |
| Bloomberg Businessweek |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.